Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05284656 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 11, 2025 (before its estimated June 12, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Results first posted: Jun 11, 2025v4 Show 5 more changesShow less
    • Primary completion date: Mar 2023 to Jun 12, 2026
    • Primary endpoint revised
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: Apr 2023 to Dec 19, 2026
    • Secondary endpoints: 2 to 1
  2. Notable Primary completion date: Jun 2022 to Mar 2023
    • Study completion date: Jul 2022 to Apr 2023
    v3
  3. Minor Interventions: Pentoxifylline 400 MG (Drug), Pentoxifylline 400 MG and Folic Acid (Drug), folic acid (Drug) to Pentoxifylline 400 MG (Drug), combination of Pentoxifylline 400 MG and Folic Acid (Drug), folic acid (Drug)v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate the effect of administration of folic acid and /or pentoxifylline on patients with chronic kidney disease (CKD).
Trial Details
NCT Number NCT05284656
Lead Sponsor Al-Azhar University
Conditions
(from sponsor)
Chronic Kidney Diseases
Related terms Renal Insufficiency, Chronic
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov